The origin of myofibroblasts in stromal reaction has been a subject of controversy. To address this question definitively, we developed techniques for purification and characterization of major stromal cell types. We defined a panel of markers that could, in combination, unequivocally distinguish these cell types by immunocytochemistry, iso-electric focusing, immunoblotting, and two-dimensional gel electrophoresis. We then devised an assay to recapitulate in culture, within two weeks of incubation, critical aspects of the microenvironment in vivo including the typical tissue histology and stromal reaction. When confronted with tumor cells in this assay, fibroblasts readily converted into a graded pattern of myogenic differentiation, strongest in the immediate vicinity of tumor cells. Vascular smooth muscle cells (VSMC), in contrast, did not change appreciably and remained coordinately smooth muscle differentiated. Midcapillary pericytes showed only a slight propensity for myogenic differentiation. Analysis of ten primary tumors implicated converted fibroblasts (10/10), vascular smooth muscle cells (4/10), and pericytes (1/10) in the stromal reaction. Tumor cells were shown to specifically denude the venules both in culture and in vivo, explaining the VSMC phenotype in the stroma. The establishment of this assay and clarification of the origin of these cells pave the way for further analysis of the mechanisms of conversion, and of the consequence of such heterogeneity for diagnosis and treatment. (J. Clin. Invest. 1995. 95:859-873.)
Introduction
Induction of molecular features of a vascular smooth muscle cell (VSMC) 1 phenotype as a universal interstitial cell response 1 . Abbreviations used in this paper: 2-D, two-dimensional; a-sm actin, a-smooth muscle actin; DME-F12, Dulbecco's modified Eagle's medium-Ham's F12; ECM, extracellular matrix; HLA-DQ, human lymphocyte antigen-DQ; IEF, isoelectric focusing; sm-myosin, smooth muscle myosin heavy chain; VSMC, vascular smooth muscle cell.
to any pertubation of tissue homeostasis such as injury, radiation, and epithelial neoplasia is a subject that has attracted much attention recently (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) . Myofibroblasts, the interstitial cells of unknown origin, are particularly frequent in the stroma of breast neoplasia (2, 3, 13, 16) . The expression of smooth muscle-specific proteins includes a-smooth muscle actin (a-sm actin), calponin and smooth muscle-myosin heavy chain (smmyosin) (2, 3, 16) . Fibroblasts appear to be an obvious candidate for such conversion (11) (12) (13) (14) . On the other hand, the striking similarity of myofibroblasts with true VSMCs and pericytes has led to speculations that myofibroblasts may originate from the vascular bed (2, 5, (17) (18) (19) . In the case of breast, this hypothesis would be compatible with the high level of angiogenesis which arises from small venules (20, 21) : at an early stage, mural cells are carried along with the endothelial sprouting (22) . A vascular origin of myofibroblasts would imply that the VSMCs migrated from the blood vessel basement membrane and left the vascular bed in favor of the interstitial collagenous stroma. In this regard, it has been shown that VSMCs which migrate into the intima of aorta in fact change into the synthetic phenotype, i.e., they partly down-regulate their smooth muscle phenotype (23, 24) . Thus, partial loss of differentiated functions of VSMCs may lead to the same end result as activation of non-muscle fibroblasts-the level of myo-differentiation being the only detectable difference. Theoretically, myoepithelial cells could also give rise to myofibroblasts if they were able to down-regulate their keratins.
It is essential to experimentally analyze the ability of resident fibroblasts, pericytes, VSMCs, and myoepithelial cells to undergo such transitions. However, studies of myofibroblasts have been hindered by problems with both purification of candidate precursor cells, and lack of culture models providing the accurate microenvironment of peritumoral stromal cells. Here, we describe a new approach by which we overcame these problems and were able to study the response of each of the cell types to tumor cells under well-controlled experimental conditions. We have developed techniques for isolation and characterization of nearly pure populations of fibroblasts, pericytes, VSMCs, and myoepithelial cells, and have developed markers for their identification.
Focusing on a-sm actin, calponin and sm-myosin, we confronted each of the three cell types with tumor cells in an organotypic assay and compared their response with that obtained in vivo with the aim of learning which cells will recapitulate the myofibroblast phenotype in this physiological setting. We believe that the evidence makes a compelling case for a scenario where myofibroblasts originate from fibroblasts > VSMCs >> pericytes. The latter phenotype is very subtle and may not fit within the conventional perception of myofi-broblasts. The availability of this model system and well-defined stromal populations will allow the investigation of the mechanisms by which the tumor cells convert these cells, and of the underlying reasons for the heterogeneity. These studies may also shed light on the factors that regulate the differentiated state of smooth-muscle characteristics in general.
Methods
Cell isolation. Stromal cells from a total of 50 different breast tissue samples were used in this study. Briefly, the tissue was minced immediately after excision in Dulbecco's modified Eagle's medium-Ham's F12 (DME-F12) supplemented with 50 pg/ml gentamicin (Garamycin, Schering, Kenilworth, NJ) and 2 mM glutamine (Sigma Chemical Co., St. Louis, MO) into fragments of -2 mm3. The tissue was then collagenase-digested at 370C for 24 h on a rotary shaker at 70 rpm in 6 ml of DME-F12 containing 900 IU/ml collagenase (CLS III; Worthington Biochemical Corp., Freehold, NJ).
Blood vessels and fibroblasts were isolated by differential centrifugation of the collagenase digest (11) . Fibroblasts were obtained by three centrifugations. First, blood vessels and epithelial organoids were pelleted by 175 g. Next, the supernatant comprising smaller blood vessels and fibroblasts was centrifuged for 5 min at 125 g, leaving the fibroblasts in the supernatant. These were finally pelleted at 500 g for 10 min. The pellet was resuspended in DME-F12 and plated in DME-F12 on T-25 flasks (Primaria', Falcon No. 3813; Becton-Dickenson, Albertslund, Denmark) or for some experiments, plated on DME-F12 supplemented with 20% fetal calf serum (FCS) for 24 h followed by serum-free DME-F12 for 3 d before co-cultivation. In other experiments, fibroblasts were used after permanent cultivation in DME-F 12 and 20% FCS on collagen coated (8 fsg/cm2 of Vitrogen 100; Collagen Corporation, Palo Alto, CA purchased from In Vitro, Copenhagen, Denmark) T-25 flasks (Nunc, Roskilde, Denmark).
Blood vessels in the first pellet were separated from epithelial organoids by resuspension of the pellet in 10 ml of medium. The epithelial organoids settled first, leaving the blood vessels in the supernatant. After further purification, the blood vessels were either rotated in DME-F12 for 24 h to wash out residual collagenase before incorporation into gels (see below) or they were mildly trypsinized to release the perivascular coat of fibroblasts (12) before centrifugation and further trypsination into single cells and plating on collagen coated flasks in DME-F12 with 20% FCS.
Purified epithelial organoids were resuspended in DME-F12 and rotated for another 24 h to detach the pre-and postcapillary arterioles and venules from terminal duct lobular units (TDLU) and interlobular ducts, respectively. The pre-and postcapillaries still attached were released by repeated resuspension. The purified fraction of TDLU and interlobular ducts were aspirated through a 27-gauge needle which resulted in fragmentation of TDLU and interlobular ducts and release of pericytes from midcapillary endothelial tubes. After a few seconds of settlement, the supernatant comprising capillaries, stripped endothelial tubes, and pericytes was centrifuged 2.5 min at 125 g. The supernatant from this centrifugation contained pericytes only. As an additional source of pericytes, we used an extended pericyte cell line generated from a focal outgrowth of cells in cultures of breast microvasculature (Ronnov-Jessen, L., 0. W. Petersen, and M. J. Bissell, manuscript in preparation). All pericytes were cultured under the same conditions as fibroblasts and VSMCs, i.e., DME-F12 supplemented with 20% FCS on collagen coated flasks. As a control for stromal cells in co-culture experiments, we used normal breast myoepithelial cells, isolated as previously described (25) and cultured on 20% FCS. For two-dimensional (2-D) gel electrophoresis epithelial cells were initially expanded on serum-free medium (CDM4) (25, 26) , followed by the same medium as used for stromal cells for 3 d before 35S-methionine incorporation (see below).
Immunocytochemistry. For immunoperoxidase cytochemistry on cultured cells or 5 ,tm cryosections of tissue (10 randomly selected primary breast tumors with myogenic stroma and two normal breast specimens) or gels (see below), the following monoclonal antibodies (mAb) were used against: a-smooth muscle actin (1A4, Sigma Chemical Co.), sm-myosin (kindly provided by Dr. M. A. Glukhova), calponin (27) , al-integrin (TS2/7, T Cell Sciences, Cambridge, CA), vimentin (VIMS, Medac), laminin (M638, Dako, Glostrup, Denmark), tenascin (M636, Dako), a cytoskeleton-associated antigen in myoepithelial cells (BG3C8 kindly provided by professor J. E. Celis, University of Aarhus, Denmark) (28), human lymphocyte antigen-DQ (HLA-DQ, Leu-10; Becton Dickenson, Alberto, Denmark), factor VIII-related antigen in endothelial cells (F8, AMD, Artarmon, Australia) and high molecular weight-melanoma-associated antigen (HMW-MAA) identical to chondroitin sulfate (MON 7004; IgGl, Monosan, Am Uden, The Netherlands). Rabbit anti-mouse immunoglobulins (Z259; Dako) were used as secondary antibody, peroxidase mouse anti-peroxidase (P850, Dako) as tertiary antibody and 3,3-diaminobenzidine with freshly added H202 was used for the peroxidase reaction (25) .
For double-and triple-labeling immunofluorescence cytochemistry, cryosections were incubated with the following primary mAbs: endothelial surface antigen (PAL-E; IgG2a, Monosan) (29) or a-sm actin (1A4; IgG2a) combined with sm-myosin (IgGI), and keratin K18 in tumor cells (Ks 18.8; IgM, Biotest, Dreieich, Germany) or al-integrin in stromal cells (IgGI). In the second sequence, goat anti-mouse IgG2a-Texas red (1080-07, Southern Biotechnology, Birmingham, AL) or goat anti-mouse IgGl-FITC (1070-02, Southern Biotechnology) were used.
For triple labeling, three sequences were necessary with goat antimouse IgM conjugated to biotin (1020-08, Southern Biotechnology) in the second sequence followed by incubation with 7-amino-4-methylcoumarin-3-acetic acid-streptavidin (STAR 61; Serotec Ltd., Oxford, England). All slides were mounted in 20 l Fluoromount G (100, Southern Biotechnology) containing 2.5 mg/ml n-propylgallate (Sigma Chemical Co.) (12) .
Isoelectric focusing (IEF), sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE), immunoblotting, and 2-D gel electrophoresis. Cells were trypsinized, quantified, and divided into two portions: one was used for protein determination and the other for IEF or SDS gels. Cell lysis, protein determination, IEF and immunoblotting with an antibody against all actins (A1804, Sigma Chemical Co.) were performed as previously described (14). For SDS gels, cells were lysed in Laemmli buffer and run at 10% separation gels and 5% stacking gels as described elsewhere (30) . Immunoblotting of SDS gels were performed as for the IEF gels (12) . 2-D gel electrophoresis was performed with cells lysed after 3 d in primary culture on 20% FCS according to the procedure described by Celis et al. (14, 31) , the only modification being the use of 3.3% carrier ampholyte, pH 4-6 (BioRad, Denmark) and pH 5-7 (Serva Feinbiochemica, purchased from Bie & Bermtsen, R0dovre, Denmark) in a 1:1 ratio. Also, fluorography was made essentially as described by Celis et al. (14, 31) . Only, 5 x 105 counts were added per gel, and they were immersed in Amplify' (Amersham, Birker0d, Denmark).
The tumor environment assay. Collagen gels (2 ml) with a final concentration of 2.04 mg/ml were prepared in six-well dishes as previously described (13) . Purified normal fibroblasts, VSMCs, or pericytes (5 X 105-1 X 106) were co-cultured with 5 X 105 of either MCF-7 (including subline 9 for serum-free experiments) or HMT-3909 S13 malignant breast epithelial cells available for both serum-supplemented and serum-free conditions (14, 32, 33) . As a rule, the cocultures were kept for 14 d in collagen gels without release from the culture dish (as anchored gels) either in DME-F12 alone or in minimum essential medium with 5% FCS (13) . Specifically, in experiments with blood vessel organoids HMT-3909 cells were used in serum-free medium to prevent spontaneous recruitment of VSMCs as elicited by serum. In one type of control experiment, the incubation time was extended to six weeks and a concentric plastic ring was placed in the center of the well to allow anchored contraction to reach a maximum without stress relaxation (34) . In another type of control experiment, the extracellular matrix was modified by co-gelifying Engelbrecht-Swarm-Holm basement membrane matrix (35) at either 10% or 50% with the collagen gels. In a final set of control experiments to test the maximal myogenic effect of tumor cells on fibroblasts, incubation was extended to 8 wk or fibroblasts were incubated simultaneously with both tumor cell lines. The medium was changed every second day and the cultures were kept at 37°C in a humidified atmosphere of 75% N2, 20% 02 and 5% Co2.
Results
In the normal breast, the interstitial fibroblasts are devoid of asm actin and sm-myosin, the expression in the stroma being limited to VSMCs (Fig. 1, a and b) . It has been shown previously that a-sm actin and sm-myosin are expressed in peritumoral stromal cells of breast carcinomas in vivo ( 1-3, 13, 16) . In some carcinomas, almost all interstitial cells express a-sm actin ( Fig. 1 c) , while sm-myosin is restricted to VSMCs ( Fig.  1 d) ; in other carcinomas a-sm actin and sm-myosin are expressed in the same cells (Fig. 1 , e and f). A search for the cellular source of this response has focused on interstitial fibroblasts, VSMCs and pericytes. In order to decipher which cells are involved and which markers could delineate the developmental history, we must have clear markers and reasonably pure cell populations.
Isolation and characterization offibroblasts, VSMCs, and pericytes. To isolate the individual stromal cell populations from breast tissue, we first defined the mural cells of the microvascular bed by immunostaining with three myogenic markers: a-sm actin, calponin and sm-myosin (Fig. 2 A) . These were selected because of their broad reactivity with both venous and arterial VSMCs compared with, for example, desmin and caldesmon, which almost exclusively decorated arterial smooth muscle cells (not shown). Midcapillary pericytes were found to have no intrinsic smooth muscle differentiation similar to what has been reported for pericytes of other microvascular beds (37, 38, 39).
They were, however, characterized by the simultaneous expression of al-integrin and chondroitin sulfate ( Fig. 2 A) (40). The phenotype of midcapillary pericytes was confirmed by immunofluorescence cytochemistry on whole-mounts of breast acini and ducts, where the entire vascular bed was exposed for analysis (data not shown). This technique, as developed by Nehls and Drenckhahn (37) , has proven indispensable in pericyte identification in situ.
Fibroblasts were released as single cells after tissue disaggregation leading to cultures that were generally > 95% pure (Fig. 2 B ; Table I ) (14). Under these culture conditions, they had no intrinsic smooth muscle differentiation-as is the case in vivo (Fig. 2, B and C). VSMCs represented a mixture of cells purified from muscular arteries, arterioles, and small veins and venules, and initially were contaminated with -20% endothelial cells and were generally > 75% pure (Table I) . The contaminating cells disappeared upon passaging. VSMCs showed a high degree of intrinsic smooth muscle differentiation (Fig. 2, B and C). Midcapillary pericytes were quite different in morphology from both VSMCs and fibroblasts. The pericyte cultures used were either primary cultures (> 65% pure) or cell lines (85% pure; Fig. 2 , B and C; Table I ; R0nnov-Jessen, L., M. J. Bissell, and 0. W. Petersen, manuscript in preparation). Midcapillary pericytes were recognized distinctly by a strong staining for both a chondroitin sulfate and al-integrin and lack of smooth muscle differentiation. Some staining for chondroitin sulfate was also seen in VSMCs of presumptive arterial origin, but these cells could be easily distinguished from pericytes because they were strongly positive for a-sm actin (Fig. 2 B) (22, 40) . To ascertain further that the separated cells were in fact different from each other beyond the above markers, we compared their two-dimensional gel protein patterns under identical culture conditions. As seen in Fig. 2 D, each cell type had its own, individual protein profile distinct from the others. The fibroblast profile resembled that previously published for human dermal fibroblasts (41) ; the VSMCs and pericytes also had distinct patterns. All differed from glandular epithelial cells. Collectively, these data led us to conclude that our cultures were sufficiently pure for a logical interpretation of the coculture experiments.
Stromal-tumor cell interactions to recapitulate the microenvironment in situ. When grown inside collagen gels in the absence of stromal cells, tumor cells formed balls with smooth edges (Fig. 3, a and b) . In contrast, when co-cultured with a mix of stromal cells, tumor cells responded by invading the collagen gel and undergoing morphological organization similar to that seen in situ (Fig. 3, c-f ). Indeed, a cross-section of such cultures is difficult to distinguish from a tumor section (compare Fig. 3 (11, (42) (43) (44) . Inside the three-dimensional collagen gels, however, the fibroblasts when cultured by themselves retain their original phenotype (45) and remain asm actin negative. On the other hand, co-culture of tumor cells with fibroblasts led to formation of a typical tumor morphology. Immunofluorescence revealed that nonreactive fibroblasts were readily converted into myofibroblasts in that almost all fibroblasts expressed a-sm actin with the highest expression in the closest vicinity of tumor cell nests (Fig. 5 A) . Significantly, expression of sm-myosin appeared in only < 5% of the cocultured fibroblasts and only in those immediately adjacent to tumor cells (Table II) . The level of calponin expression in these cells was intermediate between that of a-sm actin and smmyosin (Fig. 5 B environment primarily by partial conversion toward a myogenic phenotype with the strongest expression closest to tumor cells. Based on these criteria for a fibroblastic origin of myofibroblasts, we set out to test how often a pattern like this occurred in the stroma of tumors in vivo. We found that whereas the above described myogenic response was ubiquitously present in all tumors examined as part of a larger composite pattern (10/10, see below), a uniform and exclusive contribution from fibroblasts occurred in 5/10 (Fig. 5 A; Table II) . Co-culture with VSMCs. Inclusion of purified VSMCs in the assay resulted in a gross tumor morphology essentially resembling that of tumor/fibroblasts co-cultures. However, the complete smooth muscle differentiation program, which is the intrinsic property of these cells, was retained throughout the experimental period in the absence of both vascular organization and endothelial cells, and independently of the presence of tumor cells. Immunofluorescence revealed that the smooth muscle phenotype of VSMCs comprised the coordinate expression of a-sm actin, calponin and sm-myosin, irrespective of the cellular position relative to tumor cells (Fig. 6 A, a and b; Table II ). In addition to converted fibroblasts, four out of ten tumors contained a significant proportion of myofibroblasts resembling VSMCs (Fig. 6 A, c and d ). These were seen mainly as foci in areas of highly fibrotic tissue (desmoplasia).
For the above to be correct, one has to assume that VSMCs could, in fact, leave blood vessels in response to proximity to tumors. To test this, entire organoids of blood vessels were cocultured with tumor cells. Within one week, some of these blood vessels turned into a thin central core of cells which was left behind after an excessive migration of presumptive VSMCs into the collagen gel (Fig. 6 B) . Interestingly, some blood vessels stayed completely unaffected under the same conditions and no conversion occurred in control cultures with blood vessels alone (not shown). To identify the affected blood vessels, sections of these gels were triple stained with antibodies to tumor cells, to a venous endothelial cell surface marker, and to sm-myosin (Fig. 6 B) . It was clearly shown that the cells recruited into the tumor environment were indeed derived from VSMCs based on the strong expression of sm-myosin, and that these came predominantly from the venous portion of the vessel. This is a surprising finding. To analyzed the cytoarchitecture of blood vessels in tissue with and without high numbers of interstitial sm-myosin differentiated stromal cells. As seen in Fig. 6 B, the absence of highly myodifferentiated interstitial cells coincided with intact blood vessels; in contrast, blood vessels were essentially denuded of mural cells whenever present in areas of strong interstitial myo-differentiation, suggesting a displacement of VSMCs from the wall of the blood vessel to the interstitial stroma. The myo-differentiated stromal cells of presumptive blood vessel origin differed from those of fibroblastic origin not only by their position and by the frequent, coordinated and strong expression of a-sm actin, sm-myosin, calponin, but also by the deposition of a laminin-containing basement membrane (Fig. 6 B) .
To exclude the possibility that the vascular smooth musclelike myofibroblasts could originate from myoepithelial cells, another highly myodifferentiated cell type, these cells were isolated as previously described (26), and were confronted with the tumor cells. A radical difference between myofibroblasts and myoepithelial cells emerged in this experiment, since the latter failed to down regulate a critical keratin-associated antigen (52K), otherwise incompatible with the very definition of myofibroblasts (not shown).
Co-culture with pericytes. Tumor cells co-cultured with pericytes became motile, indicating that this particular part of tumor cell-stroma cell interaction may depend on factors shared by all three stromal cell types. However, midcapillary pericytes clearly differed from both fibroblast and VSMCs by having none, or only a very low level, of a-sm actin and calponin, and no smmyosin induced by tumor environment. These cells, however, had a distinct expression of al-integrin ( Fig. 7 ; Table II ). Of ten tumors examined in detail, only one contained areas of stroma typical of pericyte conversion. We therefore conclude that while pericytes can contribute to the tumor stroma, their conversion to a myofibroblast phenotype is quite limited. Collectively, we are therefore left with the venous VSMCs as the major candidate in the source of focal accumulations of myofibroblasts with high levels of coordinated myogenic differentiation.
Discussion
Studies of breast cancer induction, progression and metastasis have almost exclusively focused on the cancer cell (epithelia) itself. It is well known, however, that the stroma is also altered rapidly and extensively. We now know that the microenvironment of breast epithelial cells profoundly influences both the morphology and the differentiated function of the mammary gland (48, 49) . It is thus logical to suspect that the nature of the altered microenvironment would also influence the behavior of the tumor cells and may influence the course of progression. To understand the molecular basis of this interaction, however, would require a definition of the microenvironment itself and thus, a physiologically relevant culture model for breast cancer.
We have shown previously that normal and malignant breast epithelial cells can be rapidly distinguished from each other in a three-dimensional basement membrane assay (50) . To create a replica of a tumor, however, would require creating an assay where the tumor environment is reproduced as closely as possible. The latter is not possible without understanding the functional characteristics and the origin of cells in the stromal reaction. The present study, therefore, accomplishes three tasks: it provides new methods and markers for isolation and characterization of the prominent stromal cells from human breast; it provides an in depth analysis of the origin of "myofibroblasts," an early and pronounced component of the stromal reaction; and finally, it provides a versatile assay for recreating the tumor environment in culture.
The molecules reported to participate in the reactive phenotype (also described for inflammation and wound healing) are the cytoskeletal proteins desmin (17, 51), a-sm actin (1, 2), sm-myosin (16), the actin-associated proteins calponin and caldesmon (16) , the extracellular matrix receptor al-integrin ( 16, 52) , and the basement membrane molecules type IV collagen and laminin. It has been speculated that resident fibroblasts (8, (11) (12) (13) (14) , VSMCs (1, 2, 5, 18) or capillary pericytes (18) are the source of myofibroblasts. Theoretically, myoepithelial cells could also take part. We set out to provide an experimental model to test which of these hypotheses may be true. Our results indicate that myoepithelial cells are not involved, pericytes may play a small role in the tumor stroma, and the VSMCs and the fibroblasts are the primary players.
A number of potentially important findings emerges from our results. Purified, resident normal fibroblasts, once in the tumor environment assay, readily convert into a-sm actin-expressing myofibroblasts in a manner similar to that of true reactive tissue. Having established markers in addition to a-sm actin, we were able to show that the myogenic differentiation in the majority of cells is partial, both in vivo and in the culture assay: sm-myosin and calponin are only induced in a fraction of cells closest to tumor cells. We conclude that resident fibroblasts in the stroma are the cellular source of those myofibroblasts which show this pattern of conversion in vivo. Our results that the cells closest to tumor cells show the strongest conversion can be explained by a concentration gradient of growth factors originating from the tumor cells. Transforming growth factor-/3 (TGF-6) has been identified as the activity responsible for induction of a-sm actin in cultured fibroblasts and is produced by tumor cells (14, 15, 53) . We suggest that this activity may originate either from the tumor cells but be carried across the stroma by a cascade of secretion from the converted myofibroblasts. An alternative explanation would be that TGF-,6 already exists in the stroma but needs activation by proteases, and these would be elaborated by tumor cells and the converted fibroblasts. TGF-,6 is synthesized in a latent form and is often immobilized in the extracellular matrix (54, 55) . In either case, however, this growth factor would Myofibroblast Origin in Breast Cancer 867 (60) , or to appear in 10-15% of the entire cell populations (15, 44) .
Myofibroblast Origin in Breast Cancer 869 Our previous studies with purified fibroblasts have demonstrated that ectopic expression of a-sm actin is the clear result of induction at the level of mRNA in the absence of cell proliferation (14). A similar protocol for purification and cultivation of fibroblasts used in the present study allowed us to rule out proliferation-related changes, and to examine potential events that might otherwise have been obscured by overgrowth of contaminating cells.
Another major observation in the tumor environment assay is that VSMCs on the venous portion of the vessels are mobilized by the tumor cells to move towards the tumor, leaving behind denuded endothelial tubes both in the assay and in situ. Furthermore, these cells do not alter their phenotype when deprived of the endothelial tube. These findings are consistent with a contribution of VSMCs to myofibroblasts in those reactive lesions with foci of cells containing high numbers of smmyosin-expressing cells. The contribution of VSMCs to the concerted myofibroblasts scenario may explain previous puzzling results on sections of reactive tissue: that bleomycin injury of the rat lung, which leads to fibrosis and myofibroblast generation, concurrently results in disruption of blood vessels (5) , that reactive stromal cells occasionally deposit basement membrane laminin, type III and V collagen, and elastin (51, 61, 62) extracellular matrix components otherwise associated with blood vessel SMCs-and that the intermediate filament desmin, which under normal conditions is only expressed in mural cells of arteries, veins, arterioles and venules, occasionally appear at high frequencies in reactive interstitial stroma (17, 51) . That these interstitial stromal phenotypic traits in fact are derived from VSMCs is supported by our observations that sm-myosin and basement membrane laminin, when present, are not random, and are consistently co-expressed in the same focal area of cells within the tissues. That VSMCs are exclusively recruited from the venous portion of the vessel is supported by studies of 870 Ronnov-Jessen et al.
expression of caldesmon in sections of reactive stromal tissue. Caldesmon is seen primarily on the arterial portion of the blood vessels (unpublished observations) and never outside the wall of the vessel in reactive lesions (16) . Moreover, it is well established that newly formed vessels in tissue remodeling arise from smaller veins and venules only (20, 21) and that mural cells are carried along at an early stage (22) . It is quite possible, therefore, that these cells, under the prevailing paracrine conditions, and during excessive collagen deposition such as that of desmoplasia, are displaced into the interstitial stroma. In the absence of desmoplasia, angiogenesis proceeds without spillage of mural cells.
We and others have argued in the past that the differentiated state of normal cells is unstable (i.e., not constitutive), and requires continuous regulatory input (63, 64) . It can therefore be argued that there is still an alternative explanation for the interstitial focal accumulation of stromal cells with a highly coordinated myogenic phenotype: resident fibroblasts may exhibit a much more remarkable plasticity than revealed in the present tumor environment assay. Thus, a coordinated, uniform, ectopic expression of muscle genes could be turned on by master regulatory genes such as that of MyoDl (65, 66) . In the case of fibroblasts, this may still be so for the 5% of cells which are closest to the tumor. In this case, however, a local factor generated by tumor cells themselves would have to activate the master switch. Nevertheless, while this possibility cannot be absolutely ruled out for the focal areas, it is important to note that we have correlated the presence of these areas of highly differentiated myofibroblasts with the appearance of denuded vessels nearby.
Having defined the relative importance of intrinsic cellular programming and environmental regulation for the myogenic differentiation of fibroblasts and VSMCs, we widened our inquiry to include the possible conversion of pericytes. Our present and previous results show clearly that the midcapillary pericytes under normal conditions in vivo do not express a-sm actin or sm-myosin (R0nnov-Jessen, L., L. Bissell, and 0. W. Petersen, manuscript in preparation). Similar observations have been made with midcapillary pericytes from other microvasculatory beds (37, 39). Nehls et al. (37) had argued that a culture technique to obtain a-sm actin-negative pericytes was badly needed. In the present study, we used two additional markers for pericytes that we identified with our whole mount assay in situ: chondroitin sulfate and al-integrin. We were thus able to purify and identify midcapillary pericytes in culture. We find that pericytes deprived of the capillary bed in vivo and in the assay have low levels of a-sm actin but refrain from an elaborate smooth muscle differentiation and retain a I -integrin expression, an element of their original phenotype. The observed relative infrequent presence of pericytes outside the capillary bed under reactive conditions is in good agreement with previous findings on tissue sections of tumors (22, 40) .
Tumor fibroblasts have been reported to exhibit both inhibitory and stimulatory effects on the course of tumor growth and invasion (67) (68) (69) (70) . It has been shown that wounding-mediated TGF-flC is a cocarcinogen in tumors induced in chickens, and that anti-TGF-P antibodies inhibit breast cancer cell tumorigenicity in nude mice (71, 72) (for review see reference 73). Conversely, it has been suggested that a highly fibrotic, desmoplastic peritumoral stroma may have an overall negative effect on growth and invasion (74) . The diversity of stromal response both among tumors and within a tumor is indicative of dynamic cross talk and signaling among various cell types, growth factors and extracellular matrix. Therefore, the mechanism by which tumors generate the diversity and the consequences of such heterogeneity for progression and therapy must be evaluated carefully.
